
Many women come to us with generalized symptoms of perimenopause or menopause and have questions regarding their blood work. Often, we hear questions like “What are my estrogen levels?” and “What should my estrogen levels be at for my age?” It’s important to address what estrogen is and what role it plays in women’s health. Estrogen is a group of steroid hormones that play a crucial role in the female reproductive system and their overall health. It’s one of the major hormones that’s responsible for the development of female sexual characteristics, regulation of the menstrual cycle, and helps influence various other bodily functions. Estrogen levels naturally fluctuate throughout a woman's life, and understanding these changes is important when it comes to maintaining well-being.
There are three main types of estrogen in women which are primarily produced in females by the ovaries, with smaller amounts coming from the adrenal glands and fat tissue.
Estradiol (E2): The predominant circulating estrogen during the reproductive years. Values vary with cycle timing, pregnancy, medicines and the laboratory method; a single universal range is not a treatment target.
Estrone (E1): A less potent estrogen that becomes relatively more prominent after menopause. Interpret a result using the reporting laboratory and clinical context.
Estriol (E3): The weakest form of estrogen, mainly produced during pregnancy. Its role in non-pregnant women is not fully understood. Estriol levels are typically not measured in non-pregnant women.

The million-dollar question is “What does estrogen do?” Estrogen exerts its effects in women by binding itself to specific receptors in various tissues throughout the woman’s body. These receptors are found in tissue and organs such as:
Estrogen changes during puberty, menstrual cycles, pregnancy and menopause. Perimenopause can involve substantial fluctuations. New or persistent symptoms deserve assessment; heavy bleeding, bleeding between periods or any bleeding after menopause should not simply be dismissed as normal hormone changes.

The result must be considered alongside age, menstrual timing, pregnancy status, symptoms, medicines and the laboratory reference interval. A blood level alone cannot establish a need for treatment.
NICE menopause guidance recommends identifying typical perimenopause or menopause clinically in otherwise healthy people aged 45 or older. Testing has a role when the presentation is unusually early, unclear or suggests another condition.
Low estrogen levels can lead to various symptoms, including:

Menopausal hormone therapy is chosen for a clinical indication, not to reach one “optimal” estrogen number. Systemic estrogen is effective for bothersome hot flashes and night sweats and helps prevent bone loss while used.
For someone with a uterus, systemic estrogen generally needs an appropriate progestogen to protect the endometrium. ACOG explains the treatment options. Testosterone is a separate, selected treatment decision, not a routine ingredient of every menopause regimen.
The Menopause Society describes systemic and local therapy. Use only the prescribed formulation and instructions.

ERT can provide several benefits, including:
Like all medications and medical treatments ERT also carries potential risks, including:
Age, time since menopause and existing conditions affect the decision. Hormone therapy should not be prescribed solely to prevent heart disease. Unexplained bleeding, prior hormone-sensitive cancer, blood clots, stroke or liver disease require careful evaluation before systemic therapy.

ERT is not suitable for all women. It is important to discuss the benefits and risks with a licensed and experienced healthcare provider to determine if it is appropriate for you. There are several factors to consider including:

For hot flashes, evidence-based nonhormonal options include selected SSRIs/SNRIs, gabapentin and other prescription treatments. The 2023 Menopause Society position statement does not recommend clonidine, pregabalin or herbal supplements for vasomotor symptoms. This is not a list of interchangeable medicines; selection depends on the patient and product.
Fezolinetant (Veozah) has an FDA boxed warning for rare but serious liver injury. Liver tests are needed before treatment, monthly for the first three months, and at months six and nine. Stop it and seek medical advice promptly for possible liver-injury symptoms such as jaundice, dark urine, abdominal pain or unusual fatigue.
Vaginal moisturizers and lubricants can help local discomfort. Exercise, resistance training and good nutrition support overall health, but should not be promised to “balance” estrogen or eliminate hot flashes. Discuss supplements before use because ingredients and interactions vary.
For an evaluation of symptoms, medical history and treatment options, contact NovaGenix or call 561-277-8260. Medical Director Timothy Mackey, D.O., sees patients at 609 N Hepburn Ave, Suite 106, Jupiter, FL 33458.

Speak with NovaGenix about physician-led evaluation, testing, and treatment options in Jupiter, Florida.
Medical disclaimer: This article is for general educational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. Reading it does not create a physician-patient relationship. Always consult a qualified healthcare professional about your individual circumstances, and never delay seeking care because of something you read here. If you are experiencing a medical emergency, call 911. Read our full Medical Disclaimer.


609 N Hepburn avenue suite 106. Jupiter, Florida 33458
609 N Hepburn avenue suite 106. Jupiter, Florida 33458
561-277-8260
Learn what you want to know about hormone therapy by scheduling a free consultation.
Contact Us Today609 N Hepburn Ave Ste 106, Jupiter, FL 33458
Monday - Friday: 9:00 am - 5:00 pm | Saturday-Sunday: Closed